Bots, editor, reviewer, Administrators
13,951
edits
WikiJournalClub:Usable articles: Difference between revisions
Jump to navigation
Jump to search
WikiJournalClub:Usable articles (view source)
Revision as of 17:07, 6 September 2016
, 6 September 2016no edit summary
No edit summary |
No edit summary |
||
| Line 70: | Line 70: | ||
'''Cardiovascular Disease''' | '''Cardiovascular Disease''' | ||
* [[CHARISMA]] (2006): Aspirin/clopidogrel vs. aspirin for CV prevention | * [[CHARISMA]] (2006): Aspirin/clopidogrel vs. aspirin for CV prevention | ||
* [[LEADER]] (2016): Liraglutide and CVD endpoints in T2DM | |||
* [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | * [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | ||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||
| Line 119: | Line 120: | ||
* [[EMPA-REG OUTCOME]] (2015): Empagliflozin for CV outcomes in T2DM | * [[EMPA-REG OUTCOME]] (2015): Empagliflozin for CV outcomes in T2DM | ||
* [[FREEDOM]] (2012): CABG vs. PCI for CAD in T2DM | * [[FREEDOM]] (2012): CABG vs. PCI for CAD in T2DM | ||
* [[LEADER]] (2016): Liraglutide and CVD endpoints in T2DM | |||
* [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | * [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | ||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||
| Line 395: | Line 397: | ||
'''Cardiovascular Disease''' | '''Cardiovascular Disease''' | ||
* [[LEADER]] (2016): Liraglutide and CVD endpoints in T2DM | |||
* [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | * [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | ||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||
| Line 418: | Line 421: | ||
* [[FREEDOM]] (2012): CABG vs. PCI for CAD in T2DM | * [[FREEDOM]] (2012): CABG vs. PCI for CAD in T2DM | ||
* [[IDNT]] (2001): ARBs in diabetic nephropathy | * [[IDNT]] (2001): ARBs in diabetic nephropathy | ||
* [[LEADER]] (2016): Liraglutide and CVD endpoints in T2DM | |||
* [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | * [[Look AHEAD]] (2013): Weight loss and exercise in T2DM | ||
* [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | * [[ONTARGET]] (2008): Ramipril vs. telmisartan vs. both in CVD, stroke, PAD, or DM | ||